Sigma-1 receptor: The novel intracellular target of neuropsychotherapeutic drugs
Sigma-1 receptor ligands have been long expected to serve as drugs for treatment of human diseases such as neurodegenerative disorders, depression, idiopathic pain, drug abuse, and cancer. Recent research exploring the molecular function of the sigma-1 receptor started unveiling underlying mechanism...
Saved in:
Main Author: | Teruo Hayashi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Role for Sigma Receptors in Stimulant Self Administration and Addiction
by: Shang-Yi Tsai, et al.
Published: (2011) -
Sigma-1 receptor and seizures
by: Edijs Vavers, et al.
Published: (2023) -
The Roles of Intracellular Chaperone Proteins, Sigma Receptors, in Parkinson's Disease (PD) and Major Depressive Disorder (MDD)
by: Kai Yang, et al.
Published: (2019) -
Sigma Receptors
Published: (2020) -
Editorial: Sigma Receptors
by: Ebru Aydar, et al.
Published: (2020)